Market Size, Share, Trends, Growth and Forecast 2032

Industry Perspective:

The global blood group typing market size was worth USD 2,954.90 million in 2021 and is estimated to grow to USD 5093.63 million by 2028, with a compound annual growth rate (CAGR) of approximately 9.50 percent over the forecast period. The report analyzes the blood group typing market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the blood group typing market.

Request Free Sample

Blood Group Typing Market: Overview

A blood type test is a procedure to identify and determine a person's blood type. Blood types fall into one of the established classes: A, B, AB, and O. Blood type is important in transfusion to ensure that the donor's blood is compatible with the recipient's blood and is also used to determine the presence of the determinant Rh factor. Blood types are based on the presence or absence of proteins called antigens on the surface of red blood cells. Blood group typing has also been widely used in paternity testing to solve problems related to heredity and traditional paternity testing. Blood types are also used in forensic laboratories. Blood typing is also essential during pregnancy to detect and prevent the risk of hemolytic anemia in the newborn. This has contributed to the increased demand for prenatal testing and may further drive market growth in the coming years. As accidents and injuries increase worldwide, the need for blood transfusions for patients in crisis is increasing, and the demand for blood products is increasing. In addition, key players' extensive R & D activities to develop innovative and advanced automation technologies that reduce processing time and improve accuracy are another important factor contributing to the growth of market profits. However, a shortage of skilled professionals reduced blood donations, and a lack of adequate medical facilities are important factors that are expected to curb market growth to some extent during the forecast period.

Request Free Sample

Covid-19 Impact:

The outbreak of Covid-19 in the general population has dramatically reduced the number of voluntary blood donations around the world. Many donor centers in both developed and emerging countries have reduced blood donations due to social distance norms and the cancellation of blood donations.

Key Insights

• The global blood group typing market was projected at approximately USD 2,954.90 million in 2021 and is estimated to grow to about USD 5093.63 million by 2028, with a compound annual growth rate (CAGR) of around 9.50 percent over the forecast period.
• Increased demand for blood and blood products is expected to drive market growth over the forecast period.
• The lack of medical facilities can hinder market growth in the coming years.
• The growth of the hospital segment is due to the growing awareness and importance of blood donations and the increasing number of blood donations.
• North America will continue to dominate the market over the forecast period due to reimbursement for multiple surgeries and the increased prevalence of chronic diseases.

Blood Group Typing Market: Growth Drivers

Growing number of transfusion and blood donation drives the growth of the market

The increasing number of blood donations and transfusions will drive the global blood group typing market growth during the forecast period. Various nonprofits, government agencies, and other authorities have emphasized the importance of blood donations and blood transfusions. They are raising awareness through various campaigns, which are estimated to spur the market expansion.

Blood Group Typing Market: Restrains

Lack of skilled practitioners and awareness of blood donation benefits will hamper the blood group typing market growth.

Lack of awareness and lack of qualified & trained professionals can lead to misleading blood transfusions, reduced sales of blood bank reagents, and ultimately hinder the growth of the blood group typing market. Lack of awareness of the health benefits of blood donations, such as reducing the risk of cancer & heart attack and improving liver health, is anticipated to hinder market growth. Moreover, inadequate blood supply infrastructure and the risk of infectious diseases such as hepatitis B & HIV can hamper the market growth in the coming years.

Blood Group Typing Market: Segmentation

The global blood group typing market is segregated on the basis of product & service, technique, test type, end-use, and region.

By product & service, the market is divided into consumables, instruments, and services. Among these, the instruments segment dominates the market. 

By technique, the market is classified into PCR-based & microarray techniques, assay-based techniques, massively parallel sequencing techniques, and other techniques. Over the forecast period, the PCR-based & microarray techniques segment is expected to develop at the fastest rate with a large share and high growth in this segment is due to the increased prevalence of chronic diseases and increased R & D activities focused on understanding the molecular basis of blood and antibody-antigen interactions.

By test type, the market is classified into antibody screening, HLA typing, cross-matching tests, ABO blood tests, and antigen typing. The antibody screening segment dominates the market during the forecast period.

By end-user, the market is divided into hospitals, blood banks, clinical laboratories, and other end users. Over the forecast period, the hospital segment is projected to grow rapidly owing to the growing awareness of blood donations & their importance, an increasing number of blood donations, and a growing need for blood in surgery.

Recent Developments

• In April 2022, Grifols, a global pioneer in plasma-derived medicines, announced that it had acquired 100% of the equity capital of Tiancheng (Germany) Pharmaceutical Holdings AG. With the acquisition of Biotest AG, which is owned by Grifols and Tiancheng (Germany) Pharmaceutical Holdings AG, the company has accelerated and expanded its product range, improved patient access to plasma medicines, and has a private network of Europe's largest plasma facilities. 87 places) can now be operated and increase business and margin expansion
• In February 2022, Grifols announced a partnership with Endpoint Health, Inc. Grifols is a pharmaceutical company focused on solving pressing problems in immune-responsive critical care to commercialize and develop antithrombin III (AT-III) drugs for the treatment of sepsis.

Report Scope:

Blood Group Typing Market: Regional Landscape

Increasing number of transfusions is likely to help North America dominate the global market

North America gained the largest share in the global blood group typing market in 2021 due to increased blood transfusions in high-income countries such as the U. S. According to World Health Organization (WHO) data for 2019, 42% of blood donations come from high-income countries. In addition, according to the Centers for Disease Control and Prevention (CDC), about 18 million prenatal visits were made in the United States in 2015. This increases the demand for blood grouping during prenatal testing is likely to drive the regional market growth. Moreover, market players who launch new products are expected to contribute to the region's growth.

Blood Group Typing Market: Competitive Landscape

Some of the main competitors dominating the global blood group typing market include-

• Grifols
• S.A.
• Immucor
• Ortho Clinical Diagnostics
• Rapid Labs
• Quotient
• Novacyt Group 
• Bio-Rad Laboratories
• Inc BAG Healthcare GmbH 
• Day medical SA
• DIAGAST
• AXO Science.

Global blood group typing market is segmented as follows:

By Product & Service

• Consumables
• Instruments
• Services

By Technique

• PCR-based and Microarray Techniques
• Assay-based Techniques
• Massively Parallel Sequencing Techniques
• Other Techniques

By Test Type

• Antibody Screening
• HLA Typing
• Cross-matching Tests
• ABO Blood Tests
• Antigen Typing

By End User

• Hospitals
• Blood Banks
• Clinical Laboratories
• Other End Users

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa